J B CHEMICALS AND PHARMA

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on January 21, 2026.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on January 21, 2026.

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the unaudited financial results for the period ended September 30, 2025.

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 14, 2025.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 06, 2024.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about setting-up of proposed step-down subsidiary.

J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange about outcome of Board Meeting held on 11-Nov-2022 to consider financial statements for the period ended September 2022

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Board Meeting held on 04-Aug-2022 to consider financial statements for the period ended June 2022

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Board Meeting held on 26-May-2022 to consider financial statements for the period ended March 2022

J. B. Chemicals & Pharmaceuticals Limited has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 26, 2022, inter alia, to consider and approve {i) audited financial statements/annual financial results for the financial year ended on March 31, 2022; and {ii) recommendation of final dividend, if any, for financial year 2021-22.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on February 14, 2022.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 11, 2021.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on August 12, 2021.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding requests received from certain promoters and promoter group members for re- classification of status as public.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on Jun 14, 2021.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on April 01, 2021.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on February 10, 2021.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 10, 2020.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on September 14, 2020.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on Jun 25, 2020.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on February 04, 2020.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 12, 2019 Unaudited Financial Results for the quarter ended on September 30, 2019. .

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 12, 2019 -Buy-back of Equity Shares by the Company.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on August 13, 2019.

Requests received from certain promoter group members seeking re-classification of status as public under SEBI (Listing Obligations and Disclosure Requirements), 2015 as amended (��the said Regulations��)

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on May 21, 2019.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on February 08, 2019.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 02, 2018 for approving Unaudited Financial Results for the quarter ended on September 30, 2018..

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on August 31, 2018 - Buy-back of Equity Shares by the Company

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on August 10, 2018.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on February 09, 2018.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on February 09, 2018.

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange a copy of brief particulars of the results.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a Outcome of Board Meeting of the Company held on April 15, 2014.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on July 26, 2013, has approved proposal of marketing of the products in Russia-CIS region by a subsidiary of the Company in Dubai, which is hitherto undertaken by the Company. This proposal is expected to become operational during this year.

Jb Chemicals & Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 23, 2011 has approved sale of the company's Russia/CIS OTC business to Cilag GmbH International.Further the Company has submitted to the exchange a copy of release dated May 23, 2011, titled "J.B.Chemicals & Pharmaceuticals Limited to sell its Russia/CIS Over-The Counter Business to Cilag GmbH International".

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange vide its letter dated July 04, 2008 that "The Board of Directors of the Company at their meeting held today reviewed the progress and implementation of buy back of equity shares. Based on the report and consensual views of the Share Buy-back Committee, the Board has decided and approved in the larger interest of both the Company and its shareholders in their entirety the following: (1) That the proposal for buy-back as mooted at the Board Meeting held on 8th April, 2008, be abandoned for the time being. (2). That in any event no fur

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that: "The Board of Directors at their meeting held on January 22,2007, have approved and taken on record the following: 1) Unaudited Financial Results for the Third Quarter ended on December 31, 2006. 2) Setting-up of a Company (SPV) in Cyprus for making strategic investment in Biotech Laboratories (Pty) Ltd., South Africa. 3) Setting-up of a Company (SPV) for implementation of Pharmaceutical Sector - SEZ project".